Matrix Asset Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
LMFP
FWIA
DC
GI
CGH
CNB
CCMIC
Matrix Asset Advisors's MDT Position: Q2 2026 in Review
Matrix Asset Advisors increased its Medtronic (MDT) stake by 15% in Q2 2026, buying an estimated $4.68M and bringing the position to 433,672 shares worth $33.9M. The position accounts for 2.76% of the portfolio, ranked #13.
Matrix Asset Advisors first reported a position in MDT in Q1 2022 and has held it in 18 quarters since. The position peaked at $35.5M in Q4 2025. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Matrix Asset Advisors held 433,672 shares of Medtronic worth $33.9M as of Q2 2026.
- Matrix Asset Advisors bought 57,976 Medtronic shares in Q2 2026, an estimated $4.68M.
- Medtronic made up 2.76% of Matrix Asset Advisors's portfolio in Q2 2026, its #13 holding.
- Matrix Asset Advisors first reported a position in Medtronic in Q1 2022 and has held it in 18 quarters since.
- Matrix Asset Advisors's Medtronic position peaked at $35.5M in Q4 2025.
- 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Matrix Asset Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.